Filing Details

Accession Number:
0001171843-15-006620
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-02 16:31:06
Reporting Period:
2015-12-01
Filing Date:
2015-12-02
Accepted Time:
2015-12-02 16:31:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1359931 Proteon Therapeutics Inc PRTO Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1185035 P Timothy Noyes C/O Proteon Therapeutics
200 West Street
Waltham MA 02451
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-01 5,000 $1.91 5,000 No 4 M Direct
Common Stock Disposition 2015-12-01 5,000 $14.97 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.001 Par Value Stock Option (Right to Buy) Disposition 2015-12-01 5,000 $0.00 5,000 $1.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
63,742 2016-04-19 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2015.
  2. All shares were sold at a price of $14.97 per share.
  3. The option was granted on April 19, 2006. All shares underlying the option have vested.